ACE and pulmonary valve insufficiency: The APPROPRIATE study, a single-center, double-blind, placebo-controlled study, evaluated the effects of ramipril, an angiotensin-converting enzyme (ACE) inhibitor, in 64 stable patients with rTOF and moderate or severe pulmonary regurgitation.